Related Experiment Video
Updated: Jun 30, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Pregabalin-Induced Myoclonus in a Patient Without Kidney Dysfunction
Sokena Zaidi1, Patrick D Lyden1,2
1Department of Neurology, Keck School of Medicine, 1540 Alcazar Street Suite 215, Los Angeles, 90033, California, USA, usc.edu.
Pregabalin, commonly used for nerve pain and seizures, can cause rare but serious positive myoclonus. This case report highlights a patient experiencing transient neurological deficits and jerking movements, emphasizing the need for awareness of this adverse effect.
Area of Science:
- Neurology
- Pharmacology
Background:
- Pregabalin is widely prescribed for neuropathic pain and seizures.
- Common adverse effects include dizziness and somnolence.
- Renal function influences pregabalin dosing.
Purpose of the Study:
- To report a rare case of positive myoclonus associated with pregabalin use.
- To describe transient neurological deficits preceding myoclonus in a patient without renal dysfunction.
Main Methods:
- Case report presentation.
- Review of patient's medical history and medication.
- Clinical observation of neurological deficits and myoclonus.
Main Results:
- A patient on long-term pregabalin without renal impairment presented with stroke-like transient neurological deficits.
- These deficits were followed by jerking movements consistent with positive myoclonus.
- This presentation is rare, especially compared to negative myoclonus.
Conclusions:
- Pregabalin can cause positive myoclonus, a rare but serious adverse effect.
- Transient neurological deficits may precede myoclonus in pregabalin users.
- Clinicians should consider pregabalin-induced myoclonus in patients presenting with these symptoms.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

